1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on July 26, 2024

ABBV

Argus Research

6 hours ago

Analyst Report: AbbVie Inc

ABBV

Argus Research

7 hours ago

Market Update: CLS, DTE, LAZ, SKX, UL, ABBV

ABBV

MT Newswires

8 hours ago

AbbVie's Immunology Products Continue to Deliver, Morgan Stanley Says

ABBV

MT Newswires

10 hours ago

Morgan Stanley Raises Price Target on AbbVie to $211 From $196, Maintains Overweight Rating

Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
ABBV

Zacks

10 hours ago

Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News

ABBV

MT Newswires

10 hours ago

UBS Adjusts AbbVie Price Target to $185 From $172, Maintains Neutral Rating

ABBV

MT Newswires

11 hours ago

Leerink Partners Adjusts AbbVie Price Target to $196 From $173

ABBV

MT Newswires

12 hours ago

JPMorgan Adjusts AbbVie Price Target to $210 From $190

ABBV

MT Newswires

12 hours ago

Wells Fargo Adjusts AbbVie Price Target to $205 From $200

ABBV

MT Newswires

12 hours ago

Morgan Stanley Adjusts AbbVie Price Target to $211 From $196

ABBV

MT Newswires

12 hours ago

Barclays Adjusts AbbVie Price Target to $200 From $187

ABBV

MT Newswires

12 hours ago

Raymond James Adjusts AbbVie Price Target to $200 From $189

ABBV

MT Newswires

12 hours ago

Goldman Sachs Adjusts AbbVie Price Target to $200 From $190

ABBV

MT Newswires

15 hours ago

AbbVie Gets European Commission Marketing Authorization for Skyrizi to Treat Ulcerative Colitis

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
ABBV

PR Newswire

18 hours ago

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

Why AbbVie Stock Was Cruising Higher on Thursday
ABBV

Motley Fool

a day ago

Why AbbVie Stock Was Cruising Higher on Thursday

AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing
ABBV

Investor's Business Daily

a day ago

AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing

AbbVie (ABBV) Q2 2024 Earnings Call Transcript
ABBV

Motley Fool

a day ago

AbbVie (ABBV) Q2 2024 Earnings Call Transcript

ABBV

MT Newswires

a day ago

Piper Sandler Adjusts Price Target on AbbVie to $196 From $190

ABBV

Morningstar Research

a day ago

Analyst Report: AbbVie Inc.

AbbVie Stock Hits Record High on Demand for Non-Humira Portfolio
ABBV

Investopedia

a day ago

AbbVie Stock Hits Record High on Demand for Non-Humira Portfolio

AbbVie Stock Rises on Strong Sales of Immunology Drugs Other Than Humira
ABBV

Barrons.com

a day ago

AbbVie Stock Rises on Strong Sales of Immunology Drugs Other Than Humira

AbbVie stock gets lift after beating Q2 earnings estimates
ABBV

Yahoo Finance Video

a day ago

AbbVie stock gets lift after beating Q2 earnings estimates

AbbVie Slides Despite Beating Second-Quarter Views, Raising Guidance
ABBV

Investor's Business Daily

a day ago

AbbVie Slides Despite Beating Second-Quarter Views, Raising Guidance

AbbVie Stock Is Rising on Strong Earnings. CEO Cites ‘Significant Momentum.’
ABBV

Barrons.com

a day ago

AbbVie Stock Is Rising on Strong Earnings. CEO Cites ‘Significant Momentum.’

ABBV

MT Newswires

2 days ago

AbbVie Q2 Adjusted Earnings Down, Net Revenue Climbs; Raises 2024 Adjusted EPS Guidance

Is AbbVie the Best Dividend Stock for You?
ABBV

Motley Fool

2 days ago

Is AbbVie the Best Dividend Stock for You?

ABBV

Associated Press Finance

2 days ago

AbbVie: Q2 Earnings Snapshot

AbbVie lifts annual profit forecast on strong immunology drug sales
ABBV

Reuters

2 days ago

AbbVie lifts annual profit forecast on strong immunology drug sales

AbbVie Reports Second-Quarter 2024 Financial Results
ABBV

PR Newswire

2 days ago

AbbVie Reports Second-Quarter 2024 Financial Results

What Lies in Store for Healthcare ETFs in Q2 Earnings?
ABBV

Zacks

2 days ago

What Lies in Store for Healthcare ETFs in Q2 Earnings?

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences
ABBV

Zacks

2 days ago

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences

Pipeline power: Sionna’s AbbVie deal could redefine CF therapeutics
ABBV

Pharmaceutical Technology

3 days ago

Pipeline power: Sionna’s AbbVie deal could redefine CF therapeutics

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
ABBV

Zacks

3 days ago

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?

Earnings Preview: Pfizer (PFE) Q2 Earnings Expected to Decline
ABBV

Zacks

3 days ago

Earnings Preview: Pfizer (PFE) Q2 Earnings Expected to Decline

These 4 Measures Indicate That AbbVie (NYSE:ABBV) Is Using Debt Reasonably Well
ABBV

Simply Wall St.

3 days ago

These 4 Measures Indicate That AbbVie (NYSE:ABBV) Is Using Debt Reasonably Well

AbbVie Inc: An Exploration into Its Intrinsic Value
ABBV

GuruFocus.com

3 days ago

AbbVie Inc: An Exploration into Its Intrinsic Value

AbbVie's EPKINLY™ Receives First-Ever Time-Limited Reimbursement Recommendation by Canada's Drug Agency
ABBV

CNW Group

4 days ago

AbbVie's EPKINLY™ Receives First-Ever Time-Limited Reimbursement Recommendation by Canada's Drug Agency

Q2 Earnings in Full Swing This week
ABBV

Zacks

4 days ago

Q2 Earnings in Full Swing This week

AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
ABBV

Motley Fool

4 days ago

AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?

First Full Week of Q2 Earnings, PCE Out Friday
ABBV

Zacks

4 days ago

First Full Week of Q2 Earnings, PCE Out Friday

AbbVie (ABBV) Stock Before Q2 Earnings: To Buy or Not to Buy?
ABBV

Zacks

4 days ago

AbbVie (ABBV) Stock Before Q2 Earnings: To Buy or Not to Buy?

AbbVie (ABBV) Fell as its Arthritis Drug Went Off Patent
ABBV

Insider Monkey

5 days ago

AbbVie (ABBV) Fell as its Arthritis Drug Went Off Patent

What To Expect in the Markets This Week
ABBV

Investopedia

6 days ago

What To Expect in the Markets This Week

AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts
ABBV

Zacks

7 days ago

AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts

Tesla, Alphabet, Visa earnings, June PCE data: What to watch
ABBV

Yahoo Finance Video

7 days ago

Tesla, Alphabet, Visa earnings, June PCE data: What to watch

Boehringer Ingelheim offers Humira biosimilar at 92% discount
ABBV

Pharmaceutical Technology

7 days ago

Boehringer Ingelheim offers Humira biosimilar at 92% discount

Pharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data
ABBV

Zacks

7 days ago

Pharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data

Investors in AbbVie (NYSE:ABBV) have seen strong returns of 220% over the past five years
ABBV

Simply Wall St.

7 days ago

Investors in AbbVie (NYSE:ABBV) have seen strong returns of 220% over the past five years

Earnings Preview: AbbVie (ABBV) Q2 Earnings Expected to Decline
ABBV

Zacks

8 days ago

Earnings Preview: AbbVie (ABBV) Q2 Earnings Expected to Decline

Boehringer cuts price of Humira biosimilar in bid to build use
ABBV

BioPharma Dive

9 days ago

Boehringer cuts price of Humira biosimilar in bid to build use

ABBV

MT Newswires

9 days ago

GoodRx Partners With Boehringer to Offer Discounts for Humira Biosimilar

GoodRx partners with Boehringer Ingelheim to discount Humira biosimilar
ABBV

Yahoo Finance

9 days ago

GoodRx partners with Boehringer Ingelheim to discount Humira biosimilar

Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why
ABBV

Zacks

9 days ago

Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why

AbbVie’s Humira loss of exclusivity has been a missed opportunity for competitors
ABBV

Pharmaceutical Technology

9 days ago

AbbVie’s Humira loss of exclusivity has been a missed opportunity for competitors

ABBV

MT Newswires

9 days ago

TD Cowen Adjusts Price Target on AbbVie to $195 From $180

3 Absurdly Cheap Stocks to Buy and Hold for Years
ABBV

Motley Fool

9 days ago

3 Absurdly Cheap Stocks to Buy and Hold for Years

Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex
ABBV

BioPharma Dive

11 days ago

Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex

AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq
ABBV

Pharmaceutical Technology

11 days ago

AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq

AbbVie (ABBV) Files for Rinvoq in Giant Cell Arteritis in US & EU
ABBV

Zacks

11 days ago

AbbVie (ABBV) Files for Rinvoq in Giant Cell Arteritis in US & EU

Should You Be Excited About AbbVie Inc.'s (NYSE:ABBV) 75% Return On Equity?
ABBV

Simply Wall St.

11 days ago

Should You Be Excited About AbbVie Inc.'s (NYSE:ABBV) 75% Return On Equity?

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
ABBV

Motley Fool

12 days ago

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

3 Dividend Growth Stocks to Buy and Hold
ABBV

Motley Fool

13 days ago

3 Dividend Growth Stocks to Buy and Hold

3 High-Yield Dividend Stocks That Still Look Like Bargains
ABBV

Motley Fool

13 days ago

3 High-Yield Dividend Stocks That Still Look Like Bargains

ABBV

Argus Research

14 days ago

Analyst Report: AbbVie Inc

ABBV

Argus Research

14 days ago

Market Update: JPM, DAL, ABBV

ABBV

MT Newswires

14 days ago

AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis
ABBV

PR Newswire

14 days ago

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis

AbbVie (ABBV) Gains As Market Dips: What You Should Know
ABBV

Zacks

15 days ago

AbbVie (ABBV) Gains As Market Dips: What You Should Know

AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock?
ABBV

Zacks

15 days ago

AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock?

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
ABBV

Zacks

15 days ago

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

ABBV

MT Newswires

15 days ago

Morgan Stanley Adjusts Price Target on AbbVie to $196 From $191

Dividend Investors: Don't Be Too Quick To Buy AbbVie Inc. (NYSE:ABBV) For Its Upcoming Dividend
ABBV

Simply Wall St.

16 days ago

Dividend Investors: Don't Be Too Quick To Buy AbbVie Inc. (NYSE:ABBV) For Its Upcoming Dividend

The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
ABBV

Zacks

16 days ago

The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian

Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca
ABBV

Zacks

16 days ago

Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca

ABBV

MT Newswires

16 days ago

Redburn Atlantic Adjusts Price Target on AbbVie to $203 From $207

AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
ABBV

PR Newswire

16 days ago

AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer

AbbVie names new R&D head; Arcutis eczema cream approved
ABBV

BioPharma Dive

17 days ago

AbbVie names new R&D head; Arcutis eczema cream approved

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value
ABBV

GuruFocus.com

17 days ago

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value

The Smartest Dividend Stocks to Buy With $250 Right Now
ABBV

Motley Fool

19 days ago

The Smartest Dividend Stocks to Buy With $250 Right Now

ABBV

MT Newswires

21 days ago

Sector Update: Health Care Stocks Steady Premarket Friday

ABBV

MT Newswires

22 days ago

AbbVie Flags Hit to Q2 Adjusted Earnings from R&D Expenses, Revises 2024 Outlook

AbbVie cuts 2024 profit forecast on R&D expenses
ABBV

Reuters

23 days ago

AbbVie cuts 2024 profit forecast on R&D expenses

Company News for Jul 3, 2024
ABBV

Zacks

23 days ago

Company News for Jul 3, 2024

With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
ABBV

Simply Wall St.

24 days ago

With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing

AbbVie to Host Second-Quarter 2024 Earnings Conference Call
ABBV

PR Newswire

24 days ago

AbbVie to Host Second-Quarter 2024 Earnings Conference Call

2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
ABBV

Motley Fool

25 days ago

2 High-Yielding Healthcare Stocks to Buy With $1,000 in July

ABBV

MT Newswires

25 days ago

AbbVie Says Robert Michael Assumes CEO Role

AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
ABBV

Zacks

25 days ago

AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use

Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
ABBV

PR Newswire

25 days ago

Robert A. Michael Assumes Role as AbbVie Chief Executive Officer

3 Magnificent Stocks Retirees Can Buy and Hold Forever
ABBV

Motley Fool

a month ago

3 Magnificent Stocks Retirees Can Buy and Hold Forever

10 clinical trials to watch in the second half of 2024
ABBV

BioPharma Dive

a month ago

10 clinical trials to watch in the second half of 2024

How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
ABBV

Benzinga

a month ago

How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?

How Medicare drug price negotiations could hit pharma stocks
ABBV

Yahoo Finance Video

a month ago

How Medicare drug price negotiations could hit pharma stocks

Coherus offloads Humira biosimilar Yusimry for $40m
ABBV

Pharmaceutical Technology

a month ago

Coherus offloads Humira biosimilar Yusimry for $40m

AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
ABBV

Simply Wall St.

a month ago

AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
ABBV

Zacks

a month ago

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN

AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
ABBV

Zacks

a month ago

AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
ABBV

Zacks

a month ago

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

AbbVie completes acquisition of Celsius Therapeutics for $250m
ABBV

Pharmaceutical Technology

a month ago

AbbVie completes acquisition of Celsius Therapeutics for $250m

Share on Social Networks: